Cogent Biosciences, Inc.

Pharmaceutical Preparations·WALTHAM, MA·FY end 12/31·CIK 1622229

Overview Financials Compensation Governance Insiders Filings

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Andrew RobbinsChief Executive Officer	$724.6K	$13.0M	$13.4M	$583.2K	$14.0K	$27.8M
Jessica SachsChief Medical Officer	$549.4K	$4.5M	$3.7M	$333.2K	$14.0K	$9.2M
John RobinsonChief Scientific Officer	$532.0K	$4.5M	$3.7M	$322.7K	$14.0K	$9.2M
Cole PinnowChief Commercial Officer	$482.3K	$4.5M	$3.5M	$258.3K	$14.0K	$8.8M
John GreenChief Financial Officer	$510.7K	$4.0M	$3.7M	$309.6K	$14.0K	$8.5M

CEO pay mix

Andrew Robbins · FY 2025

Stock awards$13.0M47%

Performance bonus$583.2K2%

Salary$724.6K3%

Other$13.5M48%

Performance vs. pay

Item 402(v) Pay-Versus-Performance disclosure data not yet ingested for this company. Mandatory only for FYs ending on/after Dec 16, 2022 — older companies may not have filed it yet.

CEO comp · median worker · ratio — 2-year trend

CEO total compMedian employeePay ratio (right axis)